Our pipeline of novel drugs target chronic autoimmune conditions like rheumatoid arthritis, multiple sclerosis & psoriasis by modulating cellular metabolism.
Location: United Kingdom, England, London
Total raised: $7.57M
Investors 1
| Date | Name | Website |
| - | Parkwalk A... | parkwalkad... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.12.2018 | - | $7.57M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 12.12.2018 | Istesso Limited - Istesso completes £6 million fundraise | Istesso Limited (“Istesso’’) today announces that it has closed a £6 million investment round. The... | ipgroupplc... |